CTI BIOPHARMA CORP
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for CTI BIOPHARMA CORP EQUITY US CM, CUSIP 12648L601.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for CTI BIOPHARMA CORP EQUITY US CM, CUSIP 12648L601.